猫咪AV成人 Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Financial Officer 7 February 2024 | Press release
猫咪AV成人 Presents Positive Initial Phase 1/1b Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023 23 October 2023 | Press release
猫咪AV成人 to Present Initial Phase 1 Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023 5 October 2023 | Press release
IUCT-Oncopole & 猫咪AV成人 join forces to overcome resistance to therapies for familial breast cancer 13 April 2023 | Press release
猫咪AV成人 Announces Initiation of Phase 2 Randomized Trial for ATR Inhibitor ART0380 plus Gemcitabine in Patients with Platinum Resistant Ovarian Cancer 9 February 2023 | Press release
猫咪AV成人 initiates Phase 2 study of Pol胃 Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer 10 August 2022 | Press release
猫咪AV成人 Announces ATR Inhibitor, ART0380, Development On Track and Progressing Into Phase 1b Evaluation 5 April 2022 | Press release
猫咪AV成人 Appoints Nora Brennan to Board of Directors and Audit Committee Chair 16 November 2021 | Press release